Connection

Charlie Strange to Quinuclidines

This is a "connection" page, showing publications Charlie Strange has written about Quinuclidines.
Connection Strength

0.555
  1. Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy. Int J Chron Obstruct Pulmon Dis. 2017; 12:135-140.
    View in: PubMed
    Score: 0.555
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.